Health CareHealth Care Equipment & Services
  • Price (USD)154.22
  • Today's Change-0.55 / -0.36%
  • Shares traded1.41m
  • 1 Year change+35.44%
  • Beta1.0317
Data delayed at least 15 minutes, as of Sep 20 2021 21:10 BST.
More ▼
Take Survey
Help shape our future virtual events & community services
Take part in our survey for a chance to win a free 3-month standard gift subscription.

Profile data is unavailable for this security.

About the company

Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates under two segments: Diagnostic Information Services and Diagnostic Solutions. The Diagnostic Information Services develops and delivers diagnostic testing information and services, providing insights that enables a range of customers, including patients, clinicians, hospitals, integrated delivery networks (IDNs), health plans, employers, and accountable care organizations (ACOs). Its Diagnostic Solutions group includes its risk assessment services business, which offers solutions for insurers, and its healthcare information technology businesses, which offers solutions for healthcare providers. The Company's services are provided under the Quest Diagnostics brand, and other brands, such as AmeriPath, Dermpath Diagnostics, ExamOne, Quanum. It also helps in delivering diagnostic insights for COVID-19 and a range of other medical conditions for communities in South Florida.

  • Revenue in USD (TTM)11.06bn
  • Net income in USD2.24bn
  • Incorporated1996
  • Employees40.00k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
DGX:NYQ since
St Johns Mercy-Laboratory Services BusinessDeal completed08 Mar 202108 Mar 2021Deal completed30.74%--
Data delayed at least 15 minutes, as of Sep 20 2021 21:10 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Agilon Health Inc-100.00bn-100.00bn11.34bn548.00--9.86----------2.94----------------------------0.0414--53.36--44.77------
Universal Health Services, Inc.12.21bn1.08bn12.13bn68.10k11.551.877.530.993412.6412.64142.7177.950.9784--7.57179,300.208.707.3110.578.62----8.907.541.1016.160.35334.681.595.0315.776.7014.128.45
Oak Street Health Inc1.12bn-313.04m12.65bn3.20k--58.08--11.33-1.43-1.435.080.90410.9887--3.55348,874.70-27.83---40.99--5.67---28.14-----63.060.8029--58.60---56.82------
Davita Inc11.57bn883.30m12.74bn67.00k15.8410.,625.406.
Molina Healthcare, Inc.23.58bn632.00m16.24bn10.50k25.926.8121.860.688910.7310.73398.6140.862.56--13.722,245,524.006.874.5114.1310.7716.0315.902.681.84--8.900.49810.0015.416.50-8.6836.31-10.93--
Quest Diagnostics Inc11.06bn2.24bn18.91bn40.00k9.,450.0017.457.6620.318.8541.7437.2920.4010.911.2618.290.399931.2822.154.7270.6615.089.718.50
Teladoc Health Inc1.63bn-763.32m22.80bn4.40k--1.43--14.00-5.66-5.6612.52100.340.1627--12.71370,215.20-7.62-6.58-7.78-6.7867.2267.06-46.86-36.033.79-6.710.0711--97.7169.85-390.71--27.21--
Data as of Sep 20 2021. Currency figures normalised to Quest Diagnostics Inc's reporting currency: US Dollar USD

Institutional shareholders

38.56%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Jun 202113.54m11.14%
BlackRock Fund Advisorsas of 30 Jun 20216.99m5.75%
SSgA Funds Management, Inc.as of 30 Jun 20216.21m5.11%
Fiduciary Management, Inc.as of 30 Jun 20213.41m2.81%
Victory Capital Management, Inc. (Investment Management)as of 30 Jun 20213.17m2.60%
American Century Investment Management, Inc.as of 30 Jun 20213.08m2.54%
Davis Selected Advisers LPas of 30 Jun 20212.82m2.32%
Geode Capital Management LLCas of 30 Jun 20212.57m2.12%
Nordea Investment Management AB (Denmark)as of 30 Jun 20212.56m2.11%
Massachusetts Financial Services Co.as of 30 Jun 20212.53m2.08%
More ▼
Data from 30 Jun 2021 - 30 Jun 2021Source: FactSet Research Systems Inc.
Refinitiv, an LSEG business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.